Ureaplasma Infection Guidelines

Classification and Clinical Significance

• Ureaplasma species are classified as "equivocal pathogens" rather than definitive STIs, according to the Infectious Diseases Society of America (IDSA), which recommends against routine testing and treatment due to its high prevalence as a colonizer in asymptomatic, sexually active individuals 1
• The IDSA specifically states that culture or NAATs for Ureaplasma is not recommended because of the high prevalence of colonization in asymptomatic, sexually active people 1

Treatment Approach

• The CDC recommends doxycycline 100 mg orally twice daily for 7 days as first-line treatment for Ureaplasma infection, if treatment is deemed necessary based on clinical judgment 2
• Alternative regimens include azithromycin 1 g orally in a single dose or erythromycin base 500 mg orally four times a day for 7 days, according to the CDC guidelines 2
• Treatment should be considered only when Ureaplasma is detected in the context of specific clinical syndromes where other causes have been ruled out, as recommended by the Infectious Diseases Society of America (IDSA) 1

Common Pitfalls in Management

• The presence of Ureaplasma should not automatically trigger partner treatment, as is standard practice with confirmed STIs, according to the Infectious Diseases Society of America (IDSA) 1